Operating Lease, Right-of-Use Asset in USD of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Achilles Therapeutics plc quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2024 was $4.17M, a 50.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.17M -$4.21M -50.3% 30 Jun 2024 6-K 14 Aug 2024
Q4 2023 $4.37M -$3.71M -45.9% 31 Dec 2023 6-K 14 Aug 2024
Q2 2023 $8.37M 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $8.08M -$2.97M -26.9% 31 Dec 2022 20-F 04 Apr 2024
Q4 2021 $11M -$3.69M -25% 31 Dec 2021 20-F 07 Mar 2023
Q4 2020 $14.7M 31 Dec 2020 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.